Bruker (BRKR) EBITDA (2010 - 2026)

Bruker has reported EBITDA for 17 years, with the latest figure at $10.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 67.92% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $46.6 million (down 78.83% YoY), and the FY2025 full-year result was $68.2 million, down 73.05% from the prior year.
• EBITDA for Q1 2026 stood at $10.2 million, down from $76.3 million in the prior quarter.
• The five-year high for EBITDA was $131.0 million in Q4 2022, with the low at -$51.8 million in Q3 2025.
• Historically, EBITDA has averaged $51.9 million across 5 years, with a median of $53.2 million in 2022.
• Annual changes were most pronounced in 2023 — EBITDA soared 226.42% — and 2025, when it sank 176.06%.
• Bruker's EBITDA stood at $131.0 million in 2022, then decreased by 20.99% to $103.5 million in 2023, then slumped by 30.34% to $72.1 million in 2024, then gained by 5.83% to $76.3 million in 2025, then tumbled by 86.63% to $10.2 million in 2026.
• The last three EBITDA figures came in at $10.2 million (Q1 2026), $76.3 million (Q4 2025), and -$51.8 million (Q3 2025), per Business Quant data.